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NeoplasmAbstract The purpose of this study was to evaluate the role of diffusion-weighted imaging (DWI)
in diagnosis of pancreatic lesions, to compare diagnostic accuracy of conventional MRI (MRI-c),
DWI and diffusion coefﬁcient (ADC) values of lesions.
Patient and methods: Thirty-six patients with pancreatic lesions (12 malignant and 24 benign) were
included. MRI-c and DWI (b values 500 and 1000 s/mm2) were performed prospectively and
consecutively in a 1.5-T system.
Results: The analysis was retrospectively performed. The sensitivity, speciﬁcity, accuracy, and posi-
tive and negative predictive values of DWI andMRI-c were 92%, 97%, 96%, 85%, 98% and 100%,
97%, 97%, 86%, 100%, respectively. Mean ADC values of malignant lesions were signiﬁcantly
lower than those of benign lesions. DWI has a similar accuracy to MRI-c in diagnosis of pancreas
cancer.
Conclusion: Malignant tumors had lower ADC values than benign ones. DWI may be a routine
sequence in oncologic settings and it provides much useful information about tumoral tissue.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Detection of pancreatic cancer at an early stage is not satisfac-
tory by using ultrasonography, multidetector computed
tomography (MDCT) and magnetic resonance imaging
(MRI). New methods are required for early diagnosis (1,2).
Diffusion-weighted imaging (DWI) is based upon the
principles of Brownian motion of small molecules in a tissue(3,4). By using DWI, we can measure the apparent diffusion
coefﬁcient (ADC) in a given tissue. In malignant lesions, the
larger volume cells and hypercellularity lead to restriction of
the free movement of water particles. This results in a decrease
in ADC and hyperintensity signals on DWI. In contrast,
benign lesions have expanded extracellular space, with easier
diffusion of water molecules. This is displayed as high ADC
and hypointense signals on DWI (5–7). During recent years,
DWI of diseases of the lower abdomen, e.g. prostate (8),
urinary bladder (9), uterus (10) and rectum (11), has presented
promising results. DWI of the upper abdomen has been a tech-
nical challenge due to respiration, bowel peristalsis, blood ﬂow
and long acquisition times. The implementation of ultrafast
564 M.H.A. Warda et al.imaging techniques, such as parallel imaging, has made DWI
of the upper abdomen a feasible option. DWI has been found
to be useful in differentiation of malignant from benign liver
lesions (12,13). Apparent diffusion coefﬁcient (ADC) values
obtained from DWI have generally been shown to be lower
in malignant than in benign tissue. Also, ADC values are lower
in higher than lower grade tumors (14–16). At least nine
studies have demonstrated signiﬁcant lower ADC in pancreatic
adenocarcinoma than in benign pancreas tissue (17–25). The
purpose of this study was to evaluate the use of DWI in diag-
nosis of different pancreatic lesions and calculate the ADC
values for these lesions.
2. Subjects and methods
The study was approved by the local ethics committee. During
the period from October 2011 to August 2014, 36 patients
referred to our department were examined in a prospective
and consecutive manner by MRI examination with the use
of our standard comprehensive upper abdomen protocol and
additional DWI. Sixteen patients underwent pancreatic sur-
gery or had diagnostic biopsy (10 men, 6 women, mean age
57 years with their ages ranged from 46 to 61). Twenty patients
had a cross-sectional imaging follow-up (11 men, 9 women,
mean age 49 years with their ages ranged from 37 to 58).
The ﬁnal diagnoses of our cases were 12 malignant lesions
and 24 benign lesions. Malignant lesions included 9 cases with
adenocarcinoma (2 cases grade I, 4 cases grade II and 3 cases
grade III) and 3 cases with neuroendocrinal tumors. Benign
lesions included 8 cases with pseudocysts, 8 cases with mass
forming pancreatitis, 5 cases with serous cystadenoma, 2 cases
with mucinous cystadenoma and 1 case with lymphangioma.
Four patients gave history of receiving chemotherapy as down-
staging for treatment of pancreatic carcinoma.
2.1. MR protocol and parameters
– All patients were examined with a 1.5-T MR scanner
(Achieva, Philips Medical Systems) using a phased-array
body coil. All patients were examined initially with the
routine MRI protocol for the upper abdomen that included
unenhanced axial T1-weighted breath-hold spoiled gradient
echo with and without fat suppression (TR/TE, 169/4.6; ﬂip
angle, 80; number of excitations, 1), coronal and axial
T2-weighted single-shot turbo spin-echo (700/80; number
of excitations, 1; turbo spin-echo factor, 72), and axial
T2-weighted single shot turbo spin-echo with fat suppres-
sion (700/80; number of excitations, 1; turbo spin-echo
factor, 72) sequences.
– Diffusion-weighted MR imaging was performed with
single-shot spin-echo echo-planar imaging with a spectral
pre-saturation attenuated inversion recovery (SPAIR)
fat-suppressed pulse sequence. Integrated parallel imaging
techniques using generalized auto-calibrating, partially
parallel acquisitions were used with twofold acceleration.
The parameters were as follows: repetition time/echo time,
5000/80 ms; matrix, 156 · 192; bandwidth, 1446 Hz/ pixel;
section thickness, 6 mm; gap, 1.8 mm; ﬁeld of view,
300–400 mm; partial Fourier factor, 6/8; averages, 2;
parallel imaging factor of 2; free breathing; and b values
of 0, 500 and 1000 s/mm2. Typical scanning time was lessthan 2 min. ADC maps were automatically generated on a
voxel by voxel basis by using the software supplied with
the MR unit. Apparent diffusion coefﬁcient (ADC) maps
were reconstructed from these images.
– Subsequently, 0.1 mmol/kg of gadopentetate dimeglumine
(Magnevist, Bayer Schering) was administered. The patients
underwent a multiphasic contrast-enhanced MRI protocol
including arterial phase, pancreatic parenchymal phase,
and portal venous phase imaging. The arterial phase images
were initiated 25 s after the beginning of the injection of
contrast material; pancreatic parenchymal phase images,
45–55 s after contrast injection; and portal venous phase
images, 70–90 s after contrast injection.
2.2. Image analysis
(a) Detection of lesions was done by DWI. Then the DW
images correspond with ADC maps for characterizing
them as benign or malignant using b values of 500 and
1000 s/mm2 (malignant lesions have high signal on
DWI and low signal intensity on ADC map compared
with the adjacent parenchyma). All results were
recorded and the patients were classiﬁed as having
benign, malignant or no lesions at all.
(b) The ADC of lesions was attained by drawing a region of
interest (ROI) in the lesions. A free-hand (ROI) was
traced along the edge of each lesion on the ADC map.
Effort was made trying to avoid vessels, pancreatic
and common bile ducts. In cases with localized pancre-
atic lesions, the ADC of remaining normal pancreatic
parenchyma was also measured by placing a circular
ROI proximal and distal to the mass.
(c) The results of the DWI were compared with those of the
MRI examination protocol. The criteria favoring the
diagnosis of an adenocarcinoma by contrast enhanced
MRI (MRI-c) were as follows: 1- A relatively well demar-
cated lesion with decreased enhancement compared with
parenchyma in the parenchymal phase; 2- A smoothly or
beaded dilatation of the pancreatic duct with abrupt
obstruction by a mass. Imaging ﬁndings indicating a
mass forming pancreatitis were as follows: 1-Relatively
poorly demarcated lesion; 2-The pancreatic duct has a
normal or smoothly stenotic caliber inside the mass (duct
penetrating sign). Results were recorded.
2.3. Statistical analysis
Sensitivity, speciﬁcity, accuracy, and positive and negative
predictive values were calculated for DWI and MRI-c.
Comparisons of data were performed by analysis of variance.
Fisher exact test was used to control for multiplicity. Statistical
comparison testing differences between two groups were made
using the Student’s t-test. The within-group analysis was made
by using the Student’s-t test for correlated means. In order to
evaluate hypotheses of variables in contingency tables, the
Chi-square test was used or, in the case of small expected
frequencies, Fisher’s exact test. In addition to that, descriptive
statistics and graphical methods were used to characterize the
data. All analyses were carried out using the SAS system, and
Table 1 True +ve, true ve, false +ve and false ve of DWI
and MRI-c for pancreatic lesions.
True +ve True ve False +ve False ve
DWI 11 22 2 1
MRI-ca 12 22 2 –
DWI +MRI-c 12 24 – –
a Contrast enhanced MRI.
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the case of a statistically signiﬁcant result the probability value
(p) has been given.
3. Results
The ﬁnal diagnosis of the 36 patients by histopathologic
examination and follow-up was as follow: 12 patients had a
malignant lesion and 24 patients had a benign lesion. By using
DWI, eleven out of 12 malignant lesions were detected and
correctly characterized (Fig. 1 and Table. 1). All these twelve
malignant lesions were detected and correctly characterized
with MRI-c. Out of the 24 benign lesions, 22 were correctly
characterized with both DWI and MRI. Two false positive
lesions were diagnosed by DWI, including two patients with
pseudocysts (Fig. 2). There were two false positive lesions by
MRI-c, including two patients with mass forming pancreatitis
(Fig. 3). Furthermore, there was one false negative lesion by
DWI. It was a case of adenocarcinoma in a patient with a past
history of receiving chemotherapy. No false negative lesions
with MRI-c. The accuracy was 91.6% for DWI and 94.4%
for MRI-c (Table 2). The mean ADC value of the malignant
lesions was signiﬁcantly lower compared with benign lesions
(Table 3). The ADC values of malignant and benign lesions
are presented as a box plot and scatter plot in Fig. 4. From thisFig. 1 A 55-year-old male patient with histopathologically proven p
(arrow) at T1WI (a) and isointense signals (arrow) to the pancreas at T2
b values of 1000 (c) compared with the adjacent parenchyma and low
measured at the tumor area is 1.032 · 103 mm2/s (d).diagram there was clear overlap with four benign lesions being
in the range of malignant lesions. The difference between the
ADC value of the lesion and the parenchyma was signiﬁcantly
lower in malignant lesions compared with benign (p= 0.0003,
0.019 and 0.012 respectively; the latter presented in Table 3).
The ratio between the ADC value of the lesion and the parench-
yma was signiﬁcantly lower in malignant lesions compared with
benign lesions (p= 0.0004, 0.029 and 0.019 respectively
(Table 3)).
4. Discussion
In our study, The DWI showed 91.6% sensitivity and speci-
ﬁcity in differentiating benign from malignant pancreatic
lesions, which were less than those in the study of Ichikawaancreatic adenocarcinoma. The lesion showed low signal intensity
WI (b). It displays high signal intensity in DW images (arrow) with
signal intensity on corresponding ADC map, and the ADC value
Fig. 2 A 49-year-old female patient with pancreatic pseudocyst contains areas of hemorrhage. The lesion showed low signal intensity at
T1WI with hyperintense signals at anterior part (a) and hypointense signals to the pancreas at T2WI (b). It displays high signal intensity
restricted diffusion with low signals at anterior part in DW images (c) and slightly high signal intensity on corresponding ADCmap 2.51(d).
Fig. 3 A 67-year-old male patient with mass-forming focal pancreatitis of the pancreatic head. T2-weighted MRI with fat suppression
(a) shows an ill deﬁned hyperintense pancreatic head mass (arrow) (b) Diffusion weighted images show a slightly hyperintense pancreatic
head mass (arrow) with ADC values on the ADC maps, the ADC value measured at the tumor area is .91 · 103 mm2/s (c).
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Table 2 Qualitative analysis of DWI and MRI-c for pancre-
atic lesions.
DWI MRI-c DWI +MRI-c
Sensitivity (%) 91.6 100 100
Speciﬁcity (%) 91.6 91.6 100
Accuracy (%) 91.6 94.4 100
PPV (%) 84.6 85.7 100
NPV (%) 95.6 100 100
Table 3 Quantitative analysis of ADC for pancreatic lesions.
Benign Malignant P value
Mean ADC (SD) 2.42
(1.17)
1.37
(0.30)
0.0021
ADC (SD) diﬀerence
lesionparenchyma
1.29
(0.88)
0.37
(0.29)
0.87
(0.16)
ADC (SD) ratio
lesion/parenchyma
0.0024 0.012 0.019
The mean ADC value of the malignant lesions was signiﬁcantly
lower compared with benign lesions.
Fig. 4 Box plot and scatter plot of the ADC values of benign
and malignant lesions.
Differentiation of pancreatic lesions 567et al. (11) (96.2% and 98.6% respectively). Furthermore, our
results showed that, DWI of pancreas cancer has an accuracy
of 91.6%, which was comparable to that of MRI-c (94.4%). In
our study, MRI-c showed higher sensitivity than DWI. The
sensitivity and speciﬁcity of MRI-c were 100% and 91.6%
respectively. The mean ADC values of malignant lesions were
signiﬁcantly lower compared with benign lesions. There was a
considerable overlap as four benign lesions had ADC values in
the range of malignant lesions. Qualitative DWI seems to be
more accurate than the quantitative analysis and can be used
as an accurate method for detection of pancreas cancer. In
positive cases, another imaging modality as MRI-c or
MDCT will be needed for staging. By using DWI, pancreatic
cancer can be excluded with a high percentage as the NPVwas equal to 95.6%. Both the examination and the reading
time are shorter for DWI compared with MRI-c. There were
two false positive lesions by DWI in our study. There were
two cases with complicated pseudocyst as they displayed
restricted diffusion (Fig. 2). A previous study by Nicolaos
et al., stated that pseudocysts can show some grade of restric-
tion in diffusion (26). Restricted diffusion is thought to be due
to high viscosity of its content (27). There was one false nega-
tive lesion with DWI. It was adenocarcinoma in a patient with
past history of receiving chemotherapy. The three other cases
of pancreatic adenocarcinoma with past history of receiving
chemotherapy showed positive ﬁndings for malignancy on
DWI. The false negative result may represent a good response
to treatment. However, larger studies are needed to assess
whether DWI can be used to evaluate response after
chemotherapy. DWI correctly characterized the two cases with
mass forming pancreatitis that were falsely characterized as
malignant lesions on MRI-c. Takeuchi et al. (15), showed that
the inﬂammatory pseudotumors did not show high signal
intensity on DW images. The choice of b values in the applica-
tion of DWI in the upper abdomen is a compromise. Low b
values lead to contamination of other forms of intravoxel
incoherent motion such as perfusion in the capillary bed,
which results in increased ADC values (28). At high b values
a decrease in signal-to-noise ratio (SNR) is seen and long
acquisition times are required. As a compromise a b value of
500 s/mm2 was chosen. Recently, it has been reported that
higher b values, such as 1000 s/mm2, have high sensitivity
and speciﬁcity for malignant abdominal tumors (29) and in
the detection of pancreatic adenocarcinoma (13–15). The
DWI might be cost effective in screening for pancreatic malig-
nancy. Also DWI can be used for investigating patients for
whom contrast-enhanced CT or MRI studies are contraindi-
cated. In conclusion, DWI and MRI-c have nearly equal
accuracies for the detection of pancreas cancer. In positive
ﬁndings for malignancy with DWI, MRI-c examination is
probably needed for further characterization and staging.
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